Cargando…
Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage
Age-related macular degeneration (AMD) ranks third among the leading causes of visual impairment with a blindness prevalence rate of 8.7%. Despite several treatment regimens, such as anti-angiogenic drugs, laser therapy, and vitamin supplementation, being available for wet AMD, to date there are no...
Autores principales: | Nashine, Sonali, Cohen, Pinchas, Chwa, Marilyn, Lu, Stephanie, Nesburn, Anthony B, Kuppermann, Baruch D, Kenney, M Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550888/ https://www.ncbi.nlm.nih.gov/pubmed/28726777 http://dx.doi.org/10.1038/cddis.2017.348 |
Ejemplares similares
-
Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids
por: Nashine, Sonali, et al.
Publicado: (2016) -
Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022) -
Role of Resveratrol in Transmitochondrial AMD RPE Cells
por: Nashine, Sonali, et al.
Publicado: (2020) -
PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics
por: Nashine, Sonali, et al.
Publicado: (2019) -
Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs)
por: Yu, Jeffrey J., et al.
Publicado: (2021)